EDF Ventures
EDF Ventures, established in 1987, is a Michigan-based private equity firm specializing in early-stage investments across the United States. It focuses on healthcare technologies, pharmaceuticals, medical devices, diagnostics, and information technology sectors. The firm invests between $500,000 and $1.5 million initially, with follow-on investments up to $5 million. EDF Ventures leverages its extensive network to provide portfolio companies with strategic support, including management team building, partnership development, and additional funding. It prefers investments in the Midwest and Southern California, with a particular interest in technologies originating from Midwest research universities.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Michigan
TransCorp Spine
Series A in 2011
TransCorp Spine manufactures medical devices and procedures to restore spinal function and preserve healthy tissue. Its product includes SpinePort, a MIS access system.
David Lowry, Des O'Farrell, and Scott Tuinstra founded TransCorp Spine in 2008. It has its headquarters in Byron Center in Michigan.
HandyLab
Series D in 2008
HandyLab is a medical technology company that develops and manufactures molecular diagnostic assays and automation platforms
The company’s proprietary platform reduces the time, cost, and complexity of testing while improving the quality of results. Using patented real-time microfluidic PCR technology, its products are positioned to decentralize nucleic acid testing.
HandyLab was founded in 2000 and is based in Ann Arbor, Michigan. It was acquired by Becton, Dickinson and Company in 2009.
HandyLab
Series C in 2004
HandyLab is a medical technology company that develops and manufactures molecular diagnostic assays and automation platforms
The company’s proprietary platform reduces the time, cost, and complexity of testing while improving the quality of results. Using patented real-time microfluidic PCR technology, its products are positioned to decentralize nucleic acid testing.
HandyLab was founded in 2000 and is based in Ann Arbor, Michigan. It was acquired by Becton, Dickinson and Company in 2009.
HandyLab
Series B in 2002
HandyLab is a medical technology company that develops and manufactures molecular diagnostic assays and automation platforms
The company’s proprietary platform reduces the time, cost, and complexity of testing while improving the quality of results. Using patented real-time microfluidic PCR technology, its products are positioned to decentralize nucleic acid testing.
HandyLab was founded in 2000 and is based in Ann Arbor, Michigan. It was acquired by Becton, Dickinson and Company in 2009.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.